ChemoMetec Management
Management criteria checks 1/4
Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.
Key information
Martin Behrens
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | less than a year |
| Board average tenure | 3yrs |
Recent management updates
Recent updates
What ChemoMetec A/S' (CPH:CHEMM) 30% Share Price Gain Is Not Telling You
Mar 01
What Does ChemoMetec A/S's (CPH:CHEMM) Share Price Indicate?
Mar 01Earnings Beat: ChemoMetec A/S Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 08Unpleasant Surprises Could Be In Store For ChemoMetec A/S' (CPH:CHEMM) Shares
Dec 21Is It Time To Consider Buying ChemoMetec A/S (CPH:CHEMM)?
Nov 15ChemoMetec A/S (CPH:CHEMM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Sep 17A Look At The Intrinsic Value Of ChemoMetec A/S (CPH:CHEMM)
Sep 15At kr.467, Is ChemoMetec A/S (CPH:CHEMM) Worth Looking At Closely?
Jun 20With EPS Growth And More, ChemoMetec (CPH:CHEMM) Makes An Interesting Case
Jun 01Here's Why ChemoMetec (CPH:CHEMM) Has Caught The Eye Of Investors
Jan 24If EPS Growth Is Important To You, ChemoMetec (CPH:CHEMM) Presents An Opportunity
Oct 26Is It Time To Consider Buying ChemoMetec A/S (CPH:CHEMM)?
Oct 05Does ChemoMetec (CPH:CHEMM) Deserve A Spot On Your Watchlist?
Jul 18Here's Why I Think ChemoMetec (CPH:CHEMM) Is An Interesting Stock
Mar 27Do ChemoMetec's (CPH:CHEMM) Earnings Warrant Your Attention?
Dec 12Here's Why I Think ChemoMetec (CPH:CHEMM) Might Deserve Your Attention Today
Aug 29Here's Why I Think ChemoMetec (CPH:CHEMM) Might Deserve Your Attention Today
Apr 28ChemoMetec A/S' (CPH:CHEMM) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 18ChemoMetec (CPH:CHEMM) Is Growing Earnings But Are They A Good Guide?
Feb 10What Type Of Shareholders Make Up ChemoMetec A/S' (CPH:CHEMM) Share Registry?
Jan 15
Do ChemoMetec's (CPH:CHEMM) Earnings Warrant Your Attention?
Dec 20ChemoMetec A/S' (CPH:CHEMM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?
Nov 22CEO
Martin Behrens
less than a year
Tenure
Mr. Martin Helbo Behrens serves as CEO at ChemoMetec A/S since March 13, 2024. He is Chief Operating Officer of ChemoMetec A/S from December 2023. He was Vice Chief Operating Officer of ChemoMetec A/S from...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Senior Advisor | less than a year | kr.20.00k | 3.62% DKK 237.5m | |
| CEO & COO | less than a year | no data | no data | |
| Chief Financial Officer | 1.4yrs | no data | no data | |
| Chief Sales Officer | no data | no data | no data | |
| Chief Marketing & Strategy Officer | less than a year | no data | no data | |
| Head of Marketing | less than a year | no data | no data | |
| Head of R&D | no data | no data | no data | |
| Head of Finance | 1.3yrs | no data | no data | |
| Chief R&D Officer and Physicist & Project Manager | less than a year | no data | no data |
0.3yrs
Average Tenure
Erfahrenes Management: CHEMMDas Führungsteam des Unternehmens gilt nicht als erfahren ( 0.9 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 9.5yrs | kr.40.00k | no data | |
| Independent Director | 3.5yrs | no data | 0.00032% DKK 21.0k | |
| Chairman | 2.5yrs | no data | 0.0030% DKK 196.6k | |
| Independent Director | 2.5yrs | no data | 0.0017% DKK 110.1k |
3.0yrs
Average Tenure
61yo
Average Age
Erfahrener Vorstand: CHEMMDie Vorstandsmitglieder gelten als erfahren (3 Jahre durchschnittliche Amtszeit).